RB1 and cancer: We looked for mutations in cancer driver genes and revealed a wide variety of structural rearrangements disrupting RB1. In addition, we investigated mutation burden and specific mutation patterns (mutational signatures), uncovering a treatment-related mutational signature in a tumour exposed to chemotherapy.